Researchers are investigating whether GLP-1 drugs could be used to treat addiction disorders, following patient reports of reduced cravings.

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) receptor ...

Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...

Mary started drinking regularly in the early nineties, when she was thirteen. Her father had recently married a Danish woman and moved the family to Denmark, which has one of the highest teen-drinking ...

The blockbuster injections that began life as humble diabetes medications have rapidly evolved into one of modern medicine’s most surprising success stories. First they reshaped weight-loss treatment, ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION) A patient of mine, ...

A major new study out of the Department of Veterans Affairs’ St. Louis Health Care System found that GLP-1 medications, the class of drugs that includes Ozempic, Wegovy, Mounjaro and Zepbound, are ...